CASE STUDY:

Stage 3 through 5). Only half dose should be administered in standard studies unless “diagnostic benefit” of larger doses outweighs the risks. If MRA is absolutely necessary, single dose (0.1 mmol/kg) will be used. Gadolinium doses are typically single dose (0.1 mmol/kg) for non-angiographic studies and double dose (0.2 mmol/kg) for MRA. ................
................